Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 1:23 PM

Cytek Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-140.81 -101.56 533.13 494.18
PEG Ratio
2.89 0.18 -12.75 13.59
PS Ratio
4.23 6.39 8.37 17.06
PB Ratio
2.14 3.14 3.23 5.37
P/FCF Ratio
38.79 2.72K -62.15 8.21K
P/OCF Ratio
33.40 233.63 -112.28 471.45
OCF/S Ratio
0.13 0.03 -0.07 0.04
Debt / Equity Ratio
0.04 0.04 0.04 n/a
Quick Ratio
5.21 5.89 8.28 12.43
Current Ratio
5.86 6.97 9.26 13.43
Asset Turnover
0.40 0.39 0.32 0.28
Interest Coverage
n/a -13.45 -0.71 3.70
Return on Equity
-0.02 -0.03 0.01 0.01
Return on Assets
-0.01 -0.02 n/a 0.01
Return on Invested Capital
-0.05 -0.05 -0.01 0.01
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.55 0.57 0.62 0.62
Net Profit Margin
-0.03 -0.06 0.02 0.03
Pretax Profit Margin
-0.03 -0.08 0.01 0.05
Operating Profit Margin
-0.1 -0.14 -0.01 0.05
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.05 -0.02 0.06 0.08